42Stockpicking
NYSE·Healthcare·USD

Henter pris…

Værdiansættelse (TTM)

P/Ei
12,3
17th %ile · 62p
EV/EBITDAi
P/Bi
1,7
12th %ile · 64p
P/Si
0,3
8th %ile · 70p
EV/Salesi
0,3
6th %ile · 70p
Div yieldi
2,2 %
73rd %ile · 39p

Kursudvikling

Pris

Data-readiness

10 års prishistorik er idealet for høj confidence.

Beregnet 22.8.2026full
Prishistorik
30,3 år
Pris-dage
7626
Årsregnskaber
10
Peers
0/0
Valuation
5/6
Fundamentals
7/8
Datovindue
1996-04-30 til 2026-08-20

Blokkere

  • Raw confidence is below the 0.95 high-confidence guardrail.

Mangler før højere confidence

  • Kør compute-multiples for manglende valuation metrics.
  • Kør fetch-fundamentals-bulk/API fallback for manglende regnskabsmetrics.

Seneste assessment

CI vurderet 2026-08-22

Score
55.7%
Ikke high-confidence

Raw confidence is below the 0.95 high-confidence guardrail.

Sell watch placeholder

Stores exit-aware fields without issuing sell scores yet.

27%

Current drawdown: Future exit logic can use drawdown from recent high.

Trend break: Future exit logic can use moving-average trend breaks.

Valuation

Compares price paid with earnings, cash-generation proxies and sales.

89%

P/E: Reasonable P/E gets rewarded; very expensive or distressed multiples do not.

Earnings yield: Earnings yield is the inverse P/E lens.

Technicals

Checks trend, momentum and current damage from recent highs.

41%

6M momentum: Positive medium-term momentum confirms sponsorship.

Trend stack: Strong setup keeps price above MA50 and MA200 with MA50 above MA200.

Data quality

Checks whether the assessment has enough recent price, fundamental and valuation data.

75%

Price history depth: More than one trading year gives the technical pillar enough context.

Latest price freshness: Latest live or EOD price should be recent.

Macro/regime

Treats macro as context, not a standalone trading instruction.

47%

VIX: Normal volatility is supportive; panic or complacency is less clean.

10Y-2Y curve: Positive yield curve lowers recession stress.

Fundamentals

Scores growth, margins, capital efficiency, balance-sheet resilience and composite financial-health KPIs.

61%

Revenue growth 3Y: Sustained top-line growth supports durable compounding.

Gross margin: High gross margin gives room for reinvestment and downturns.

Peer/relative context

Adds relative context when sector peers have comparable data.

65%

Peer count: Peer context is only scored when comparable data exists.

P/E vs peers: Own P/E 12.3 vs peer median 20.6; cheaper than peers if business quality is comparable.

Insider activity

Net 90d (aktier)
-23.012
Net 90d (værdi)
-6.386.552 USD
Købere 90d
0
Cluster
DatoPersonRolleTypeAntalVærdiKilde
18.8.2026Jones Nicole SSee Remarks▼ SALG-2.677-748.516 USDsec
5.8.2026Jones Nicole SSee Remarks◆ OPT.1.301249.818 USDsec
4.8.2026Jones Nicole SSee Remarks◆ OPT.14.0452.696.921 USDsec
4.8.2026Jones Nicole SSee Remarks▼ SALG-19.436-5.369.584 USDsec
12.6.2026Kates Jamie GChief Accounting Officer▼ SALG-899-268.452 USDsec
12.6.2026Kates Jamie GChief Accounting Officer◆ OPT.899137.452 USDsec
1.6.2026Koka Durga PrasadEVP, Global CIO· ANDET-729-200.861 USDsec
13.5.2026Cordani DavidChairman & CEO◆ OPT.15.4582.305.329 USDsec
12.5.2026Cordani DavidChairman & CEO◆ OPT.103.59515.449.640 USDsec
12.5.2026Cordani DavidChairman & CEO▼ SALG-3.903-1.119.505 USDsec

Earnings

QuarterDateEPS actualEPS estEPS surpriseRevenue surprise
2026Q230.7.20267,787,60+2.4%+2.4%Inline
2026Q130.4.20267,797,61+2.4%+2.4%Inline
2025Q430.1.20268,087,88+2.5%+2.5%Inline
2025Q330.10.20257,837,64+2.5%+2.5%Inline
2025Q230.7.20257,207,15+0.7%+0.7%Inline